Global Market Direct’s pharmaceuticals report, “Alzinova AB - Product Pipeline Review - 2013” provides data on the Alzinova AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Alzinova AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Alzinova AB and industry-specific third party sources, put together by Global Markets Direct’s team.
- Alzinova AB - Brief Alzinova AB overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Alzinova AB human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Alzinova AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Alzinova AB’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Alzinova AB’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Alzinova AB in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Alzinova AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Alzinova AB. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Alzinova AB and identify potential opportunities in those areas.
Table Of Contents
Alzinova AB - Product Pipeline Review - 2013 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Alzinova AB Snapshot 4 Alzinova AB Overview 4 Key Information 4 Key Facts 4 Alzinova AB - Research and Development Overview 5 Key Therapeutic Areas 5 Alzinova AB - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Alzinova AB - Pipeline Products Glance 9 Alzinova AB - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Alzinova AB - Drug Profiles 11 ALZ-101 11 Product Description 11 Mechanism of Action 11 RandD Progress 11 ALZ-102 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 ALZ-103 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 ALZ-201 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 ALZ-301 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 Alzinova AB - Pipeline Analysis 16 Alzinova AB - Pipeline Products by Therapeutic Class 16 Alzinova AB - Pipeline Products By Target 17 Alzinova AB - Pipeline Products By Mechanism of Action 18 Alzinova AB - Locations And Subsidiaries 19 Head Office 19 Appendix 20 Methodology 20 Coverage 20 Secondary Research 20 Primary Research 20 Expert Panel Validation 20 Contact Us 21 Disclaimer 21
List of Tables
Alzinova AB, Key Information 4 Alzinova AB, Key Facts 4 Alzinova AB - Pipeline by Indication, 2013 6 Alzinova AB - Pipeline by Stage of Development, 2013 7 Alzinova AB - Monotherapy Products in Pipeline, 2013 8 Alzinova AB - Preclinical, 2013 9 Alzinova AB - Discovery, 2013 10 Alzinova AB - Pipeline By Therapeutic Class, 2013 16 Alzinova AB - Pipeline By Target, 2013 17 Alzinova AB - Pipeline Products By Mechanism of Action, 2013 18
List of Figures
Alzinova AB - Pipeline by Indication, 2013 6 Alzinova AB - Pipeline by Stage of Development, 2013 7 Alzinova AB - Monotherapy Products in Pipeline, 2013 8 Alzinova AB - Pipeline By Therapeutic Class, 2013 16